文献速递乳腺US乳腺X线

在钼靶阴性的病理性乳头溢液患者中,超声联合乳管造影对评估的价值

The Value of Adding Ductography to Ultrasonography for the Evaluation of Pathologic Nipple Discharge in Women with Negative Mammography.
PubMed 文献 · Korean J Radiol · 2022-01-01

研究回顾性纳入101例钼靶阴性的病理性乳头溢液女性,评估初始超声、乳管造影及乳管造影后超声对恶性肿瘤的诊断效能。乳管造影和乳管造影后超声的敏感度均为94.1%,显著高于初始超声的47.1%;乳管造影后超声的阴性预测值96.9%显著高于初始超声的83.3%。联合应用乳管造影与超声对检出恶性肿瘤具有高敏感度,乳管造影所见有助于在二次超声上定位病变。

要点

  • 钼靶阴性病理性乳头溢液患者中,初始超声仅检出17例恶性肿瘤中的8例。
  • 乳管造影和乳管造影后超声敏感度均为94.1%,显著高于初始超声的47.1%。
  • 乳管造影后超声阴性预测值96.9%,显著高于初始超声的83.3%。

核心结论

  • 联合应用乳管造影与超声对钼靶阴性的病理性乳头溢液患者检出恶性肿瘤具有高敏感度,乳管造影所见可在乳管造影后二次超声上定位病变,从而有助于选择最佳治疗方案。

研究设计与样本

  • 回顾性研究,纳入2003年7月至2018年12月共101例钼靶阴性的病理性乳头溢液女性(平均年龄46.3±12.2岁,范围23-75岁),均行乳管造影前(初始)超声、乳管造影及乳管造影后超声;以手术(70例)或超声随访>2年(31例)为标准参考。

诊断标准与关键数值

  • 乳管造影检测恶性肿瘤的敏感度为94.1%(16/17),乳管造影后超声为94.1%(16/17),初始超声为47.1%(8/17);乳管造影后超声的阴性预测值为96.9%(31/32),初始超声为83.3%(45/54);初始超声特异度显著高于乳管造影和乳管造影后超声(P=0.001)。

临床应用与阅片要点

  • 在钼靶阴性的病理性乳头溢液患者中,乳管造影可检出初始超声未显示的恶性肿瘤,乳管造影后二次超声可定位其中8/9的病变以供超声引导干预;初始超声特异度显著高于乳管造影和乳管造影后超声(P=0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The optimal imaging approach for evaluating pathological nipple discharge remains unclear. We investigated the value of adding ductography to ultrasound (US) for evaluating pathologic nipple discharge in patients with negative mammography findings.

MATERIALS AND METHODS: From July 2003 to December 2018, 101 women (mean age, 46.3 ± 12.2 years; range, 23-75 years) with pathologic nipple discharge were evaluated using pre-ductography (initial) US, ductography, and post-ductography US. The imaging findings were reviewed retrospectively. The standard reference was surgery (70 patients) or > 2 years of follow-up with US (31 patients). The diagnostic performances of initial US, ductography, and post-ductography US for detecting malignancy were compared using the McNemar's test or a generalized estimating equation.

RESULTS: In total, 47 papillomas, 30 other benign lesions, seven high-risk lesions, and 17 malignant lesions were identified as underlying causes of pathologic nipple discharge. Only eight of the 17 malignancies were detected on the initial US, while the remaining nine malignancies were detected by ductography. Among the nine malignancies detected by ductography, eight were detected on post-ductography US and could be localized for US-guided intervention. The sensitivities of ductography (94.1% [16/17]) and post-ductography US (94.1% [16/17]) were significantly higher than those of initial US (47.1% [8/17]; p = 0.027 and 0.013, respectively). The negative predictive value of post-ductography US (96.9% [31/32]) was significantly higher than that of the initial US (83.3% [45/54]; p = 0.006). Specificity was significantly higher for initial US than for ductography and post-ductography US (p = 0.001 for all).

CONCLUSION: The combined use of ductography and US has a high sensitivity for detecting malignancy in patients with pathologic nipple discharge and negative mammography. Ductography findings enable lesion localization on second-look post-ductography US, thus facilitating the selection of optimal treatment plans.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Choi Y, Kim SM, Jang M, et al. The Value of Adding Ductography to Ultrasonography for the Evaluation of Pathologic Nipple Discharge in Women with Negative Mammography. Korean J Radiol. 2022. PMID: 36047541. doi:10.3348/kjr.2021.0850

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。